Matthew Gallagher didn't build a clinical system. He plugged into one.
On 2 April 2026, the New York Times published a story that stopped the startup world. Gallagher had built Medvi — a GLP-1 telehealth company — to $401 million in first-year revenue. No VC money. No team. No office. Just a house in Los Angeles, a stack of AI tools, and two white-label clinical platforms.
He didn't employ doctors. He didn't build a pharmacy. He didn't write clinical software. He found infrastructure that already existed, plugged into it, and poured every ounce of his energy into the customer-facing layer above it.
"It's not an AI company, but I did it with AI."
— Matthew Gallagher, New York Times, April 2026This playbook gives you the exact map he used — updated with the compliance guardrails he learned the hard way, the moat strategy he never built, and the unit economics model to validate yours before you spend a penny on ads.